Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
04/2002
04/11/2002WO2002029036A2 Lipid metabolism enzymes
04/11/2002WO2002029030A2 Ethanol production
04/11/2002WO2002029029A2 Nucleotide sequences which code for the cysd, cysn, cysk, cyse and cysh genes of c. glutamicum
04/11/2002WO2002029027A1 Immobilized dna polymerase
04/11/2002WO2002029026A2 Human proteases and polynucleotides encoding the same
04/11/2002WO2002029025A2 Factor vii glycoforms
04/11/2002WO2002029024A1 Nucleic acids encoding polypeptides having proteolytic activity
04/11/2002WO2002029023A1 Nicastrin protein
04/11/2002WO2002029022A2 Chlorophyllases
04/11/2002WO2002029021A2 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle
04/11/2002WO2002029020A1 Process for the fermentative preparation of d-pantothenic acid using coryneform bacteria
04/11/2002WO2002029019A2 2.5-diketo-d-gluconic acid reductases and methods of use
04/11/2002WO2002029018A2 Divinyl ether synthase gene and protein, and uses thereof
04/11/2002WO2002029017A2 Nls-tankyrase fusion proteins and their use in screening methods
04/11/2002WO2002029016A2 Thermostable polymerase based on thermococcus pacificus
04/11/2002WO2002028906A2 Regulation of human sphingosine kinase-like protein
04/11/2002WO2002028406A2 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases
04/11/2002WO2002028369A1 Coated particles containing an active substance
04/11/2002WO2002028175A2 Transgenic mouse for targeted recombination mediated by modified cre-er
04/11/2002WO2002002739A3 Ubiquitin ligase
04/11/2002WO2002000924A3 Viral phospholipase a2 enzymes, anti-viral agents and methods of use
04/11/2002WO2002000891A3 Human napsin-like aspartyl protease
04/11/2002WO2001097854A3 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics
04/11/2002WO2001096536A3 Aspartic acid proteases and nucleic acids encoding same
04/11/2002WO2001092494A3 50250, a human lipase and uses thereof
04/11/2002WO2001092310A3 Regulation of human transketolase-like enzyme
04/11/2002WO2001090312A9 Ammonia-oxidizing bacteria
04/11/2002WO2001083768A3 Serine-threonine kinase
04/11/2002WO2001081602A3 Mre11 orthologue and uses thereof
04/11/2002WO2001081558A3 13295 novel protein kinase molecules and uses therefor
04/11/2002WO2001079513A3 Process for modifying plants
04/11/2002WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
04/11/2002WO2001068822A3 Method of treating phenylketonuria and means therefor
04/11/2002WO2001066758A3 25934, a novel fatty acid desaturase and uses therefor
04/11/2002WO2001055320A3 Nucleic acids, proteins, and antibodies
04/11/2002WO2001055316A3 Nucleic acids, proteins, and antibodies
04/11/2002WO2001051647A3 Method for increasing the content of fatty acids in plants and micro-organisms
04/11/2002WO2001007578A3 Subtilisin protease variants having amino acid substitutions in defined epitope regions
04/11/2002WO2000063689A9 Detecting and suppressing malignancy based on expression of spleen tyrosine kinase (syk)
04/11/2002WO2000058523A9 Glucocorticoid receptor agonist and decreased pp5
04/11/2002WO2000049164A9 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
04/11/2002WO2000028008A9 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase
04/11/2002WO2000011188A9 Transgenic microbial polyhydroxyalkanoate producers
04/11/2002US20020042933 Desaturating omega-6 fatty acid with recombinant polypeptide
04/11/2002US20020042932 Recombinant vector containing prokaryotic gene from bacillus or intestinal bacteria including ubiquitin promoter that targets cytosol or plastid of host plant, enhancing photosynthetic efficiency
04/11/2002US20020042930 Regulation and manipulation of sucrose content in sugarcane
04/11/2002US20020042503 Diagnosis, drug screening, clinical trial monitoring, and disease treatment
04/11/2002US20020042499 Novel inhibitor of the inflammatory response induced by TNF-alpha and IL-1
04/11/2002US20020042386 Genetic engineering
04/11/2002US20020042373 Administering thrombin receptor antagonist; bone disorders
04/11/2002US20020042371 Genetic engineering
04/11/2002US20020042369 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
04/11/2002US20020042368 Integrin antagonists
04/11/2002US20020042358 Sphingosine kinase, cloning, expression and methods of use
04/11/2002US20020042144 Preventing agglomeration of bodily fluid; obtain body fluid sample, incubate with enzyme inhibitors, monitor body fluid agglomeration
04/11/2002US20020042123 yybQ
04/11/2002US20020042120 Enzymatic polypeptides for use in starch degradation, food preparation and cosmetics
04/11/2002US20020042119 Novel Metalloproteinases
04/11/2002US20020042118 Isolated nucleic acid fragment encoding said proteins and chimeric microorganisms tranformed with said fragments capable of expressing phenol-induced proteins
04/11/2002US20020042117 Genes encoding picric acid degradation
04/11/2002US20020042116 Polypeptide for use in the treatment of vision defects
04/11/2002US20020042115 Regulation of human S-acyl fatty acid synthase thioesterase-like enzyme
04/11/2002US20020042114 Novel human protein kinases
04/11/2002US20020042110 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
04/11/2002US20020042107 Microorganism; for use in the generation of preferential amino acid for animal nutrition
04/11/2002US20020042106 Nucleotide sequences which code for the cma gene
04/11/2002US20020042105 Nucleotide sequences coding for the pknB gene
04/11/2002US20020042104 Generation of preferential compounds in culture; obtain genetically engineered microorganism, culture, recover preferential compounds
04/11/2002US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy
04/11/2002US20020042099 2504, 15977, and 14760, novel protein kinase family members and uses therefor
04/11/2002US20020042098 32253 transferase family members and uses therefor
04/11/2002US20020042097 Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
04/11/2002US20020042096 Nucleic acids, proteins, and antibodies
04/11/2002US20020042055 For dehalogenating hydrocarbons to produce alcohols, polyols, epoxides
04/11/2002US20020042052 Method of removing nucleic acid contamination in amplification reactions
04/11/2002DE10133668A1 Für das gpmB-Gen kodierende Nukleotidsequenzen For The Board gene coding nucleotide sequences
04/11/2002DE10117085A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung coryneformer Bakterien A process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
04/11/2002DE10113957A1 Neue für das def-Gen kodierende Nukleotidsequenzen New coding for the def gene nucleotide sequences
04/11/2002DE10109685A1 Neue für das sahH-Gen kodierende Nukleotidsequenzen New coding for the sahH gene nucleotide sequences
04/11/2002DE10052319A1 New nucleic acid encoding mutant factor 7 activating protease, useful for diagnosis, treatment and prevention of coagulation disorders, also related protein and antibodies
04/11/2002DE10049937A1 New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis
04/11/2002DE10047864A1 Neue für das truB-Gen kodierende Nukleotidsequenzen New coding for the lees gene nucleotide sequences
04/11/2002DE10047403A1 Neue für das ppgK-Gen kodierende Nukleotidsequenzen New coding for the pPGK gene nucleotide sequences
04/11/2002DE10046960A1 Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen A process for producing an active heterodimeric AMV RT in prokaryotic cells
04/11/2002DE10046625A1 Neue für das ndkA-Gen kodierende Nukleotidsequenzen New coding for the ndkA gene nucleotide sequences
04/11/2002CA2425126A1 Lipid metabolism enzymes
04/11/2002CA2424953A1 Novel human proteases and polynucleotides encoding the same
04/11/2002CA2424890A1 Ethanol production in gram-positive bacteria with a stabilized mutation in lactate dehydrogenase
04/11/2002CA2424738A1 Retroviral vectors containing internal ribosomal entry sites
04/11/2002CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases
04/11/2002CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same
04/11/2002CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
04/11/2002CA2422214A1 Factor vii glycoforms
04/11/2002CA2358853A1 Use of acetyl amino acid racemase from amycolatopsis orientalis for racemisation of carbomoyl amino acids
04/10/2002EP1195435A1 Truncated phosphodiesterase-7 polypeptides
04/10/2002EP1195433A2 Respiratory chain enzyme genes of coryneform bacteria
04/10/2002EP1195431A1 Process for producing l-lysine
04/10/2002EP1195163A1 Serine protease inhibitor
04/10/2002EP1194595A1 Polymorphisms in the human hmg-coa reductase gene
04/10/2002EP1194578A2 Enhanced expression of proteins using gfp